Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$2,011.59

7.19 (0.36%)

, TSLA

Tesla

$307.30

-3.1 (-1.00%)

12:01
10/02/18
10/02
12:01
10/02/18
12:01

Fly Intel: Wall Street's top stories at midday

The Dow hit an all-time high in morning trading with a triple digit move as relief over a new trade agreement in North America continues to benefit blue-chip stocks more than small-caps. While the S&P and Nasdaq were not as strong, both were modestly higher near noon after searching for direction in the early hours of trading. ECONOMIC EVENTS: In the U.S., no economic reports of note were reported. In energy news, U.S. crude oil prices rose to their first multi-year high in more than three months before pulling back to trade near $75 a barrel on the New York Mercantile Exchange. The recent strength in the commodity may be attributable to investors anticipating supply shortages due in part to U.S. sanctions on Iran. COMPANY NEWS: Amazon (AMZN) announced plans to raise the minimum wage for all its U.S. employees to $15, effective November 1, and encouraged its "competitors and other large employers" to join in the action. The pay hike comes amid a wave of criticism from politicians, led by Senator Bernie Sanders, about the e-commerce giant's treatment of warehouse workers... Tesla (TSLA) announced that it produced 80,142 vehicles, including 53,239 Model 3 vehicles, in the third quarter and delivered 83,500 vehicles, including 55,840 Model 3s. Following the production and delivery update, Tesla shares are down 1% near noon. Other automakers also issued sales reports this morning, with both Ford (F) and General Motors (GM) reporting U.S. sales declines. However, Ford's report covered only September while GM's was for the entire third quarter, as the latter no longer issues monthly sales reports... PepsiCo (PEP) shares slipped 1% after the snack foods and beverage giant reported better than expected quarterly results but trimmed its full-year profit forecast due to the impact of foreign exchange rates. MAJOR MOVERS: Among the noteworthy gainers was Lamb Weston (LW), which rose 9% after reporting earnings. Also higher was Clovis Oncology (CLVS), which gained 12% after the FDA granted Breakthrough Therapy designation for Rubraca for the third line treatment of patients with BRCA mutated metastatic castrate-resistant prostate cancer. Among the notable losers was Ring Energy (REI), which slid 19% after Seaport Global analyst John Aschenbeck downgraded the stock to Neutral and cut his price target on the shares to $12 from $20. Also lower was Stitch Fix (SFIX), which dropped 31% after reporting quarterly results. INDEXES: Near midday, the Dow was up 127.19, or 0.48%, to 26,778.40, the Nasdaq was up 9.60, or 0.12%, to 8,046.90, and the S&P 500 was up 4.58, or 0.16%, to 2,929.17.

AMZN

Amazon.com

$2,011.59

7.19 (0.36%)

TSLA

Tesla

$307.30

-3.1 (-1.00%)

PEP

PepsiCo

$109.33

-1.5 (-1.35%)

GM

General Motors

$33.65

-0.55 (-1.61%)

F

Ford

$9.28

-0.04 (-0.43%)

LW

Lamb Weston

$71.56

5.74 (8.72%)

CLVS

Clovis

$32.50

3.345 (11.47%)

REI

Ring Energy

$8.47

-2.19 (-20.54%)

SFIX

Stitch Fix

$30.85

-13.85 (-30.98%)

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 04

    Oct

  • 04

    Oct

  • 05

    Oct

  • 09

    Oct

  • 17

    Oct

  • 29

    Oct

  • 13

    Nov

AMZN Amazon.com
$2,011.59

7.19 (0.36%)

10/02/18
WELS
10/02/18
NO CHANGE
WELS
Amazon, eBay 'ramping their ad games,' says Wells Fargo
After performing a deep-dive analysis of online retailers' opportunity in online advertising, Wells Fargo analyst Peter Stabler concludes that the effort remains in early days, with untapped ad demand among CPG advertisers, potential tailwinds from increasing ad coverage and improved ad targeting, an emerging opportunity among non-endemic advertiser categories, and ongoing development of online retailers' ad technology and supporting partner ecosystems. The analyst estimates that Amazon's (AMZN) pureplay retail ad business will generate nearly $7B of revenue this year, with other display and video ads to generate about $2B in gross revenue. Stabler argues that Amazon is well ahead of the online retail pack in terms of audience scale and engagement, ad platform development, and sales/partner execution, but is also still in the early days of penetrating its opportunity across retail. Additionally, the analyst believes eBay (EBAY) is also well positioned but may face more limited opportunity.
10/01/18
KEYB
10/01/18
NO CHANGE
KEYB
Amazon represents ongoing threat to mattress industry, says KeyBanc
KeyBanc analyst Bradley Thomas says that he came across several mattress models launched under the AmazonBasics brand on Amazon. While not a surprise, the analyst believes the launch warrants monitoring. Initially, Thomas thinks this line will likely take share from other lower-price online brands, rather than having an effect on the middle or upper price points. Nonetheless, the analyst believes Amazon represents an ongoing threat to most of the traditional side of the industry.
10/02/18
LOOP
10/02/18
NO CHANGE
Target $2200
LOOP
Buy
Amazon's 'savvy' wage hike to minimally impact profitability, says Loop Capital
Loop Capital analyst Anthony Chukumba views the Amazon.com's announcement of a minimum wage hike to $15 per hour as a "savvy move" that should result in lower fulfillment center employee turnover. The news is a "public relations victory" for Amazon, Chukumba tells investors in a research note. Further, he believes the wage increase will have a "fairly limited" on the company's overall profitability. The analyst keeps a Buy rating on Amazon with a $2,200 price target.
10/02/18
LOOP
10/02/18
NO CHANGE
Target $15
LOOP
Hold
Bed Bath & Beyond pricing gap with Amazon narrowed in August, says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Hold rating and $15 price target on Bed Bath & Beyond (BBBY), saying his channel checks indicate a further narrowing of the pricing gap with Amazon (AMZN). The analyst notes the gap in August has shrunk to 13.6% on average vs. 16.9% in July, but also warns that given its position as the "most dynamic retailer" in the U.S. in terms of pricing, Amazon can "quickly and easily lower prices if top-line growth underperforms".
TSLA Tesla
$307.30

-3.1 (-1.00%)

10/02/18
BARD
10/02/18
NO CHANGE
Target $411
BARD
Outperform
Tesla shares likely to move higher into Q3 report, says Baird
Baird analyst Ben Kallo said he expects Tesla shares to move higher into the company's full Q3 report as he thinks its deliveries are good enough to support strong financial results. Kallo noted that average Model 3 production grew substantially from 2,198 per week in Q2 to about 4,100 per week in Q3, which he views favorably. The analyst keeps a Fresh Pick designation on Tesla shares with an Outperform rating and $411 price target.
10/02/18
WOLF
10/02/18
INITIATION
Target $295
WOLF
Peer Perform
Tesla initiated with a Peer Perform at Wolfe Research
Wolfe Research initiated Tesla with a Peer Perform and $295 price target.
10/01/18
ADAM
10/01/18
NO CHANGE
Target $316
ADAM
Hold
Musk's settlement with SEC 'positive' for Tesla, says Canaccord
Canaccord analyst Jed Dorsheimer says he believes Elon Musk's settlement with the Securities and Exchange Commission will be "positive" for Tesla shares, as it should improve governance and allow investors to focus solely on the operations. However, the analyst believes the "distractions" have likely impacted operations and now predicts a miss in Model 3 production, at 48,000 vs. expectations of 50,000-55,000. Dorsheimer, who maintains a Hold rating and $316 price target on Tesla shares, says he would become more constructive as details of who the new chairman and independent directors might be or a significant improvement in the operations and profitability of the company.
10/01/18
RBCM
10/01/18
NO CHANGE
RBCM
Sector Perform
Tesla SEC settlement is a positive outcome, says RBC Capital
RBC Capital analyst Joseph Spak kept his Sector Perform rating on Tesla after its CEO Elon Musk settled the SEC charges against him for $40M combined and announced his resignation as the Board chairman. The analyst says it was a positive outcome for the company as it will allow it to continue raising capital and keep Musk as the CEO. Spak adds that the outcome of splitting a CEO and chairman positions is also a sign of management "maturity", with hopes that a "true check" on Musk will emerge to bring more accountability on the company's claims and targets.
PEP PepsiCo
$109.33

-1.5 (-1.35%)

08/14/18
EVER
08/14/18
NO CHANGE
EVER
BodyArmor stake positive for Coca-Cola, negative for Pepsi, says Evercore
Evercore ISI analyst Robert Ottenstein views Coca-Cola's stake in BodyArmor as a "clear positive" for the company and a "clear negative" for both PepsiCo (PEP) and Keurig Dr Pepper (KDP). Pepsi's Gatorade product is most at risk with Coca-Cola taking a stake in BodyArmor, and Keurig Dr Pepper "losses distribution of the product and any path to ownership it might have enjoyed," Ottenstein tells investors in a research note.
09/13/18
GUGG
09/13/18
INITIATION
GUGG
Neutral
PepsiCo initiated with a Neutral at Guggenheim
07/23/18
JEFF
07/23/18
NO CHANGE
Target $107
JEFF
Hold
Jefferies sees risk of near-term downside in PepsiCo shares
Jefferies analyst Kevin Grundy sees potential near-term downside in shares of PepsiCo. Despite fundamental challenges and weak earnings quality, PepsiCo's "relative multiple remains elevated," Grundy tells investors in a research note. The analyst is "negatively biased" toward PepsiCo and reiterates a Hold rating on the shares with a $107 price target.
07/24/18
RHCO
07/24/18
NO CHANGE
Target $110
RHCO
Hold
PepsiCo price target raised to $110 from $105 at SunTrust
SunTrust analyst William Chappell raised his price target on PepsiCo to $110 to account for gains related to the impact of refranchising transactions, which he expects to support the company's high-single-digit EPS growth trend going forward. The analyst also keeps his Hold rating on PepsiCo as the stock is "fairly valued", with the company's Beverage business trading in line with peers and the Food business trading at the high end of its large-cap snack food peer range.
GM General Motors
$33.65

-0.55 (-1.61%)

09/19/18
VERF
09/19/18
NO CHANGE
VERF
Sell
E-tron may not be 'Tesla killer,' but still a 'real risk,' says Vertical Group
After attending Audi's (AUDVF) launch event for its e-tron SUV, Vertical Group analyst Gordon Johnson said he sees Audi's foray in the EV space as "a real risk" to Tesla (TSLA) and other EV auto makers including Chevy (GM) and Ford (F). The Electrify America charging network, owned by a JV of Audi parent Volkswagen (VLKAY) and funded by "Dieselgate," positions Audi's fast-charging ambitions among the most robust, if not the most robust, in the U.S. currently, added Johnson. He does not see Audi's forthcoming e-tron as a "TSLA Killer," but does not "see it a stretch to think of it as a potential TSLA Model X killer," he concludes in his note to investors. Johnson keeps a Sell rating on Tesla shares.
09/11/18
GSCO
09/11/18
INITIATION
Target $36
GSCO
Neutral
General Motors reinstated with a Neutral at Goldman Sachs
Goldman Sachs analyst David Tamberrino reinstated coverage of General Motors with a Neutral rating and $36 price target. Before going Not Rated on the name, Goldman had a Sell rating on the shares. The path forward for the shares is "somewhat murky" with a "more challenged" backdrop in North America and growing concerns about the potential for China joint venture income to see further pressure, Tamberrino tells investors in a research note. The analyst sees positives from GM's pickup truck refresh and Korea restructuring accruing in 2019, but still expects a "downward trajectory" to earnings and free cash flow next year. However, he believes the market is prepping for a flat-to-down earnings trajectory and views the stock's risk/reward as balanced at current levels.
09/11/18
09/11/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Krystal Biotech (KRYS) initiated with an Overweight at Cantor Fitzgerald. 2. Melinta Therapeutics (MLNT) initiated with a Buy at H.C. Wainwright and Jefferies. 3. Burlington Stores (BURL) initiated with an Overweight at Barclays. 4. General Motors (GM) reinstated with a Neutral at Goldman Sachs. 5. SailPoint (SAIL) initiated with a Market Perform at Northland. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/11/18
RBCM
09/11/18
NO CHANGE
Target $49
RBCM
Outperform
General Motors valuation reflects 'low expectations', says RBC Capital
RBC Capital analyst Joseph Spak kept his Outperform rating and $49 price target on General Motors after hosting meetings with its CEO Mary Barra and CFO Dhivya Suryadevara. The analyst says he remains positive on the company's execution, adding that while investors are focused on China and the direction of earnings in FY19, he believes that the market expectations are already "very low" with forward valuation multiple ex-Cruise and ex-cash at just over 3.5-times earnings. Spak also cites the positives for General Motors from the " recovering volume on light-duty pickups", cost savings, and expectations of strong performance in the mid-size CUV class.
F Ford
$9.28

-0.04 (-0.43%)

08/20/18
MSCO
08/20/18
NO CHANGE
Target $15
MSCO
Overweight
Ford risks high, but so is potential reward, says Morgan Stanley
Morgan Stanley analyst Adam Jonas believes Ford announcing plans to spend $11B on restructuring and then canceling its investor day may have may have the unintended consequence of raising expectations for a "big bang" of action. While acknowledging the wide range of potential outcomes, Jonas has an estimate for how Ford could recognize its planned $11B in restructuring charges over a 3-5 year period to achieve annual cost reductions of about $4B, giving it a payback period of just under 3 years that would "usually [be] a very good use of capital" by automotive standards, he tells investors. Jonas maintains an Overweight rating on Ford with a $15 price target, contending that the "risks are high, but so is the potential reward."
09/26/18
LEHM
09/26/18
NO CHANGE
Target $11
LEHM
Equal Weight
Ford price target lowered to $11 from $12 at Barclays
In a research note titled "'Going Further' isn't further enough," Barclays analyst Brian Johnson lowered his price target for Ford Motor to $11 and $12 and keeps an Equal Weight rating on the name. Likely restructuring plans are not enough to get us interested, Johnson tells investors after Ford cancelled its investor day. Ford's plan borrows ideas from other manufacturers around shifting product toward trucks, exiting unattractive geographies and rationalizing architectures, the analyst contends. He says that even if successful, he sees little earnings upside and limited potential for multiple expansion for Ford shares.
09/10/18
SBSH
09/10/18
NO CHANGE
Target $9.9
SBSH
Neutral
Ford price target lowered to $9.90 from $10.50 at Citi
Citi analyst Itay Michaeli lowered his price target for Ford (F) to $9.90 to reflect restructuring-related calls on cash. The analyst keeps a Neutral rating on the shares and continues to maintain his preference for General Motors (GM). Ford faces both fundamental and perception problems, whereas GM just faces the latter, Michaeli tells investors in a research note. While the company must deal with some legitimate China and trade headwinds, the degree of erosion that's implied by the pullback in the shares is overdone, the analyst contends.
LW Lamb Weston
$71.56

5.74 (8.72%)

06/07/18
JEFF
06/07/18
NO CHANGE
Target $71
JEFF
Buy
Jefferies sees minimal impact on Lamb Weston from Mexico potato tariff
Lamb Weston shares sold off yesterday morning on news that Mexico has imposed a 20% tariff on U.S. frozen potato exports, Jefferies analyst Akshay Jagdale tells investors in a research note. Mexico represents 1%-2% of Lamb's sales and the tariff is likely temporary, the analyst adds. Further, he believes a good portion of the volumes will be sourced from other North American exporters like Canada. As such, Jagdale thinks the impact will be "relatively immaterial" on Lamb Weston and the industry. He has a Buy rating on the shares with a $71 price target.
05/22/18
05/22/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hostess Brands (TWNK) initiated with a Buy at Vertical Research. 2. DocuSign (DOCU) initiated with an Outperform at William Blair and JMP Securities, an Overweight at Piper Jaffray and JPMorgan, a Buy at Citi, an Equal Weight at Morgan Stanley, and a Hold at Deutsche Bank. 3. Goosehead Insurance (GSHD) was initiated with an Outperform at Keefe Bruyette, an Overweight at JPMorgan, and a Buy at BofA/Merrill. 4. Smartsheet (SMAR) was initiated with an Outperform at William Blair and RBC Capital, an Overweight at JPMorgan and Morgan Stanley, as well as a Buy at Jefferies, SunTrust, and Canaccord. Lamb Weston (LW) initiated with a Sell at Vertical Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/27/18
JEFF
07/27/18
NO CHANGE
Target $80
JEFF
Buy
Lamb Weston price target raised to $80 from $71 at Jefferies
Jefferies analyst Akshay Jagdale raised his price target for Lamb Weston to $80 saying the company's Q4 results continue to point to favorable industry dynamics. He believes management's guidance will likely end up being conservative and maintains a Buy rating on the shares.
08/24/18
JEFF
08/24/18
NO CHANGE
Target $80
JEFF
Buy
Lamb Weston recent share weakness overdone, says Jefferies
Jefferies analyst Akshay Jagdale attributes the 6% pullback in shares of Lamb Weston since August 14 to fears surrounding a poor European potato crop and, to a lesser extent, concerns about global trade policies. While some near-term caution is warranted, the recent stock reaction is overdone, Jagdale tells investors in a research note. The analyst lowered his estimates to account for the "near-term transitory headwinds in Europe" but keeps a Buy rating on the shares with an $80 price target.
CLVS Clovis
$32.50

3.345 (11.47%)

09/24/18
LEER
09/24/18
INITIATION
Target $30
LEER
Market Perform
Clovis initiated with a Market Perform at Leerink
Leerink analyst Andrew Berens started Clovis Oncology with a Market Perform rating and $30 price target.
10/02/18
JPMS
10/02/18
NO CHANGE
JPMS
Overweight
JPMorgan increasingly confident in Clovis Oncology's rucaparib
JPMorgan analyst Cory Kasimov is encouraged by Clovis Oncology's announcement this morning that rucaparib received breakthrough designation from the FDA for the third line treatment of patients with BRCA mutated metastatic castrate-resistant prostate cancer on the basis of data from the Triton-2 study. The analyst says the news further increases his confidence in the potential for rucaparib to produce response rates that are meaningfully better than currently available options. His model implies $9 per share for prostate, assuming a 55% probability of success and $450M in peak unadjusted sales. Kasimov keeps an Overweight rating on Clovis, which is up 11%, or $3.33, to $32.47 in morning trading.
09/17/18
GUGG
09/17/18
INITIATION
Target $75
GUGG
Buy
Clovis initiated with a Buy at Guggenheim
Target $75.
09/21/18
JPMS
09/21/18
NO CHANGE
Target $71
JPMS
Overweight
Clovis price target lowered to $71 from $87 at JPMorgan
JPMorgan analyst Cory Kasimov lowered his price target for Clovis Oncology to $71 after "reigning in" his ovarian expectations but keeps an Overweight rating on the shares. With the European Society of Medical Oncology meeting coming up in October, Kasimov is previewing the first look at data from Clovis's Triton-2 study in prostate cancer. The analyst is "quite confident" that the company's PARP inhibitor rucaparib should produce response rates that are well above chemotherapy and anti-androgens, at least in third line BRCA positive patients. He views the Triton-2 update as an important event for Clovis and believes "promising results could represent a step towards restoring more favorable sentiment." A response rate of at least 30% is the lower bar for share appreciation, Kasimov tells investors in a research note. He keeps an Overweight rating on Clovis.
REI Ring Energy
$8.47

-2.19 (-20.54%)

02/06/18
RILY
02/06/18
INITIATION
Target $22
RILY
Buy
Ring Energy initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Rehan Rashid started Ring Energy with a Buy rating and $22 price target.
10/02/18
GHSC
10/02/18
DOWNGRADE
GHSC
Neutral
Ring Energy downgraded to Neutral from Buy at Seaport Global
Seaport Global analyst John Aschenbeck downgraded Ring Energy to Neutral and cut its price target to $12 from $20. The analyst has looked at state data obtained from DrillingInfo and come to the conclusion that Ring's 2018 hz. San Andres completions have been underperforming older vintages by approximately 25%, and his prior type curve estimates by 34%.
03/28/18
ROTH
03/28/18
NO CHANGE
Target $50.5
ROTH
Buy
Concho acquisition of RSP may be catalyst for Permian consolidation, says Roth Capital
Roth Capital analyst John White notes that Concho Resources (CXO) and RSP Permian announced they have entered into a definitive agreement under which the former will acquire the latter in an all-stock transaction valued at approximately $9.5B, inclusive of RSP's net debt. The analyst believes this transaction could potentially be a catalyst for additional consolidation in the Permian Basin. White points out that there are a large number of small and mid-cap operators active in the basin, including Approach Resources (AREX), Callon Petroleum (CPE), Diamondback Energy (FANG), Earthstone Energy (ESTE), Halcon Resources (HK), Laredo Petroleum (LPI), Matador (MTDR), Parsley Energy (PE), Ring Energy (REI). The analyst has a Buy rating and $50.50 price target on RSP Permian's shares.
06/14/18
IMPC
06/14/18
NO CHANGE
IMPC
Outperform
Imperial Capital sees attractive valuations for Permian names
The market has overreacted to the "inevitable traffic jams and competition for outbound transportation" taking place in the Permian region, Imperial Capital analysts Irene Haas and Jason Wangler tells investors in a research note. Following conversations with industry participants in both the upstream and midstream arenas of the Permian Region, the analysts believes relief for oil could materialize in early 2019. They sees a "handful of high quality Permian names at attractive valuations," including Diamondback Energy (FANG), Resolute Energy (REN), Ring Energy (REI), Callon Petroleum (CPE), Matador Resources and PDC Energy (PDCE).
SFIX Stitch Fix
$30.85

-13.85 (-30.98%)

10/02/18
STFL
10/02/18
NO CHANGE
Target $30
STFL
Hold
Stitch Fix price target raised to $30 after 'mixed' Q4 at Stifel
Stifel analyst Scott Devitt said Stitch Fix reported "mixed" Q4 results with adjusted EBITDA above consensus and revenue growth modestly below analysts' expectations. While he supports management's selected areas of investment, Devitt believe the stocks' current valuation reflects the company's attractive growth opportunities. He raised his price target on Stitch Fix shares to $30 from $26 following the earnings report and maintains a Hold rating on the stock.
09/25/18
JPMS
09/25/18
NO CHANGE
Target $36
JPMS
Neutral
Stitch Fix price target raised to $36 from $26 at JPMorgan
JPMorgan analyst Doug Anmuth raised his price target for Stitch Fix to $36 but keeps a Neutral rating on the shares. The stock is up 110% since the company's fiscal Q3 earnings report on June 7, which the analyst attributes to a widely held view that management's Q4 guidance is conservative and consensus fiscal 2019 estimates are too low. He agrees that the Q4 guidance has upside potential. However, while Anmuth remains confident in Stitch Fix's market opportunity, he like to see another quarter or two of 25%-plus revenue growth and better margin visibility before getting more constructive on the name.
10/02/18
PIPR
10/02/18
NO CHANGE
Target $31
PIPR
Overweight
Stitch Fix price target lowered to $31 from $43 at Piper Jaffray
Piper Jaffray analyst Erinn Murphy lowered her price target for Stitch Fix to $31 saying the outlook for Q1 suggests the company's core growth is moderating. The analyst remains on the sidelines with respect to the shares and keeps a Neutral rating on Stitch Fix.
09/20/18
09/20/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BAIRD UPGRADES CATERPILLAR TO OUTPERFORM: Baird analyst Mig Dobre upgraded Caterpillar (CAT) to Outperform from Neutral. The analyst believes demand growth should continue into 2019. While some markets like China are close to peak, most of its demand is still at or below mid-cycle levels, said Dobre, who raised his price target to $191 from $155 on Caterpillar shares. Caterpiller is up 1.5% in late morning trading. PIPER CUTS STITCH FIX TO NEUTRAL: Piper Jaffray analyst Erinn Murphy downgraded Stitch Fix (SFIX) to Neutral while raising her price target for the shares to $43 from $29. The analyst cited valuation for the downgrade. With shares nearing $50, market expectations do not provide any margin of error, Murphy said. She believes the "smallest hint" of pressure could be a significant negative catalyst for the stock. Further, the analyst notes that Amazon's (AMZN) Prime Wardrobe is now advertising in key NFL slots and that the company is testing a personalized recommendation service for certain categories. In late morning trading, Stitch Fix is lower by over 13%. COWEN CUTS SKECHERS TO MARKET PERFORM: Cowen analyst John Kernan downgraded Skechers (SKX) to Market Perform from Outperform citing growing inventory levels, particularly as foreign exchange headwinds in key markets build. He also believes consensus forecasts for operating expansion are too optimistic. Kernan lowered his price target to $28 from $32 on Skechers shares, which are down 4.7% in late morning trading. JPMORGAN CUTS GE'S PRICE TARGET: JPMorgan analyst Stephen Tusa lowered his price target for General Electric (GE) to $10 from $11 and kept an Underweight rating on the shares. The impact on "asset value" from a failure at GE's U.S. H-frame launch customer, while tough to estimate, represents a negative development for a company that has little wiggle room for more "shoes to drop," Tusa said. MORGAN STANLEY POSITIVE ON APPLE IPHONE DUAL-SIM ADDITION: In EMEA and Asia, smartphones with dual-SIM capabilities have become the status quo, noted Morgan Stanley analyst Katy Huberty, who believes that Apple adding dual-SIM to the new iPhones is an underappreciated feature with the potential to drive upside to shipments in FY19. Huberty kept an Overweight rating and $247 price target on Apple shares.

TODAY'S FREE FLY STORIES

22:20
10/18/18
10/18
22:20
10/18/18
22:20
General news
China's GDP slowed to a 6.5% y/y growth pace in Q3 »

China's GDP slowed…

NI

NiSource

$25.25

0.22 (0.88%)

21:12
10/18/18
10/18
21:12
10/18/18
21:12
Downgrade
NiSource rating change at Goldman Sachs »

NiSource downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

PNW

Pinnacle West

$83.48

-0.235 (-0.28%)

21:04
10/18/18
10/18
21:04
10/18/18
21:04
Upgrade
Pinnacle West rating change at Goldman Sachs »

Pinnacle West upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 11

    Nov

  • 11

    Nov

NVS

Novartis

$86.24

0.9 (1.05%)

20:26
10/18/18
10/18
20:26
10/18/18
20:26
Hot Stocks
Novartis granted orphan status for melanoma treatment »

The FDA granted Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

PG

Procter & Gamble

$80.31

-0.8628 (-1.06%)

, HON

Honeywell

$155.22

-2.73 (-1.73%)

20:25
10/18/18
10/18
20:25
10/18/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$80.31

-0.8628 (-1.06%)

HON

Honeywell

$155.22

-2.73 (-1.73%)

SLB

Schlumberger

$58.43

-0.81 (-1.37%)

VFC

VF Corp.

$87.07

-2.22 (-2.49%)

STT

State Street

$79.62

-2.5 (-3.04%)

STI

SunTrust

$61.46

-0.94 (-1.51%)

SYF

Synchrony

$29.63

-0.45 (-1.50%)

CFG

Citizens Financial

$34.92

-0.96 (-2.68%)

KSU

Kansas City Southern

$102.68

-1.31 (-1.26%)

IPG

Interpublic Group

$22.48

0.28 (1.26%)

EEFT

Euronet

$112.64

-2.96 (-2.56%)

MAN

Manpower

$78.38

-1.09 (-1.37%)

GNTX

Gentex

$18.62

-0.32 (-1.69%)

CLF

Cleveland-Cliffs

$11.47

-0.37 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 24

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 06

    Nov

  • 26

    Nov

  • 26

    Nov

  • 06

    Dec

  • 03

    Mar

CP

Canadian Pacific

$199.27

-6.68 (-3.24%)

20:24
10/18/18
10/18
20:24
10/18/18
20:24
Upgrade
Canadian Pacific rating change at National Bank »

Canadian Pacific upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

DWDP

DowDuPont

$58.60

-0.98 (-1.64%)

19:57
10/18/18
10/18
19:57
10/18/18
19:57
Hot Stocks
DowDuPont clarifies the charge is the result of previously reported conditions »

In response to market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLP

Valero Energy Partners

$39.94

0.5 (1.27%)

19:35
10/18/18
10/18
19:35
10/18/18
19:35
Downgrade
Valero Energy Partners rating change at RBC Capital »

Valero Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

IVZ

Invesco

$21.26

0.32 (1.53%)

19:33
10/18/18
10/18
19:33
10/18/18
19:33
Downgrade
Invesco rating change at Credit Suisse »

Invesco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

LOGC

LogicBio Therapeutics

$0.00

(0.00%)

19:31
10/18/18
10/18
19:31
10/18/18
19:31
Syndicate
LogicBio Therapeutics 7M share IPO priced at $10.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

MDSO

Medidata

$70.91

1.54 (2.22%)

19:07
10/18/18
10/18
19:07
10/18/18
19:07
Recommendations
Medidata analyst commentary at JPMorgan »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

TSLA

Tesla

$263.85

-8.09 (-2.97%)

18:58
10/18/18
10/18
18:58
10/18/18
18:58
Periodicals
Tesla rolls out new Model 3 with 'mid-range' battery pack, Electrek reports »

Tesla today is rolling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Dec

SKX

Skechers

$26.05

-0.64 (-2.40%)

, PYPL

PayPal

$77.50

-2.61 (-3.26%)

18:51
10/18/18
10/18
18:51
10/18/18
18:51
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

SKX

Skechers

$26.05

-0.64 (-2.40%)

PYPL

PayPal

$77.50

-2.61 (-3.26%)

CE

Celanese

$97.01

-2.76 (-2.77%)

CP

Canadian Pacific

$199.27

-6.68 (-3.24%)

ISRG

Intuitive Surgical

$522.41

-20.44 (-3.77%)

AXP

American Express

$102.86

-1.53 (-1.47%)

ETFC

E-Trade

$48.89

-1.68 (-3.32%)

VLP

Valero Energy Partners

$39.94

0.5 (1.27%)

VLO

Valero

$103.31

-0.36 (-0.35%)

FBC

Flagstar Bancorp

$29.26

-0.33 (-1.12%)

OZK

Bank OZK

$34.85

-1.57 (-4.31%)

LLNW

Limelight Networks

$5.07

0.12 (2.42%)

TEAM

Atlassian

$81.96

-1.67 (-2.00%)

AIG

AIG

$48.62

-0.99 (-2.00%)

SREV

ServiceSource

$2.60

-0.08 (-2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 25

    Oct

  • 29

    Oct

  • 29

    Oct

  • 05

    Nov

  • 07

    Nov

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

  • 05

    Dec

  • 06

    Dec

X

U.S. Steel

$27.91

-0.27 (-0.96%)

, AKS

AK Steel

$4.69

-0.115 (-2.39%)

18:47
10/18/18
10/18
18:47
10/18/18
18:47
Periodicals
U.S. requests WTO panel to examine metals tariffs retaliation, Reuters says »

The U.S. has asked the…

X

U.S. Steel

$27.91

-0.27 (-0.96%)

AKS

AK Steel

$4.69

-0.115 (-2.39%)

NUE

Nucor

$58.26

-0.85 (-1.44%)

STLD

Steel Dynamics

$41.32

0.77 (1.90%)

AA

Alcoa

$38.85

2.14 (5.83%)

CENX

Century Aluminum

$9.91

-0.23 (-2.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 25

    Oct

  • 26

    Oct

  • 02

    Nov

RLH

Red Lion Hotels

$12.62

-0.42 (-3.22%)

18:43
10/18/18
10/18
18:43
10/18/18
18:43
Hot Stocks
Red Lion Hotels CFO Douglas Ludwig resigns due to personal health reasons »

RLH Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

IDA

IDACORP

$96.78

0.035 (0.04%)

18:30
10/18/18
10/18
18:30
10/18/18
18:30
Hot Stocks
IDACORP declares quarterly dividend of 63c per share »

Director of IDACORP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRYS

Krystal Biotech

$20.70

-0.59 (-2.77%)

18:08
10/18/18
10/18
18:08
10/18/18
18:08
Syndicate
Krystal Biotech 3M share Secondary priced at $20.00 per share »

Cowen, William Blair and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

FBC

Flagstar Bancorp

$29.26

-0.33 (-1.12%)

, SVU

Supervalu

$32.49

0.02 (0.06%)

18:05
10/18/18
10/18
18:05
10/18/18
18:05
Hot Stocks
S&P announces changes to S&P SmallCap 600 index »

S&P Dow Jones Indices…

FBC

Flagstar Bancorp

$29.26

-0.33 (-1.12%)

SVU

Supervalu

$32.49

0.02 (0.06%)

UNFI

United Natural Foods

$26.94

0.2 (0.75%)

TTGT

TechTarget

$19.53

-0.35 (-1.76%)

PERY

Perry Ellis

$27.48

0.02 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 23

    Oct

  • 28

    Oct

  • 07

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

SXT

Sensient

$76.67

-1.15 (-1.48%)

18:02
10/18/18
10/18
18:02
10/18/18
18:02
Hot Stocks
Sensient raises quarterly dividend to 36c from 33c per share »

The cash dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

DWDP

DowDuPont

$58.60

-0.98 (-1.64%)

18:02
10/18/18
10/18
18:02
10/18/18
18:02
Hot Stocks
DowDuPont says Sept. quarter results won't be impacted by $4.5B goodwill charge »

On October 18, 2018, E.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$3.54

-0.13 (-3.54%)

17:55
10/18/18
10/18
17:55
10/18/18
17:55
Hot Stocks
Northern Oil and Gas sees Q4 production 58% greater than Q2 »

Liquidity has increased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SHPG

Shire

$176.90

-0.4 (-0.23%)

17:47
10/18/18
10/18
17:47
10/18/18
17:47
Hot Stocks
FDA advisory committee recommends Shire's Prucalopride for CIC »

Shire announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 21

    Dec

ACN

Accenture

$156.20

-2.76 (-1.74%)

, T

AT&T

$32.50

-0.06 (-0.18%)

17:37
10/18/18
10/18
17:37
10/18/18
17:37
Hot Stocks
CACI, IBM, Northrop Grumman and more compete for orders on $37.4B Army contract »

Accenture Federal…

ACN

Accenture

$156.20

-2.76 (-1.74%)

T

AT&T

$32.50

-0.06 (-0.18%)

CACI

CACI

$181.34

-2.07 (-1.13%)

HII

Huntington Ingalls

$233.27

0.15 (0.06%)

CMTL

Comtech

$32.05

-0.95 (-2.88%)

IBM

IBM

$130.52

-3.53 (-2.63%)

JEC

Jacobs Engineering

$73.01

-0.89 (-1.20%)

KFRC

Kforce

$35.15

-0.49 (-1.37%)

LLL

L3 Technologies

$218.17

-1.965 (-0.89%)

LDOS

Leidos

$66.72

-0.97 (-1.43%)

NOC

Northrop Grumman

$308.21

-1.04 (-0.34%)

RTN

Raytheon

$191.62

-1.48 (-0.77%)

KEYW

KEYW

$8.31

-0.27 (-3.15%)

VSEC

VSE Corp.

$30.75

-1.13 (-3.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 31

    Oct

  • 01

    Nov

  • 06

    Nov

  • 08

    Nov

  • 12

    Nov

  • 13

    Nov

  • 13

    Nov

  • 03

    Mar

UBSFY

Ubisoft

$0.00

(0.00%)

, BBY

Best Buy

$72.63

-1.2 (-1.63%)

17:31
10/18/18
10/18
17:31
10/18/18
17:31
Periodicals
Certain boxes of new Ubisoft game from Best Buy didn't include game, Kotaku says »

A number of Best Buy…

UBSFY

Ubisoft

$0.00

(0.00%)

BBY

Best Buy

$72.63

-1.2 (-1.63%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

AXP

American Express

$102.86

-1.53 (-1.47%)

17:28
10/18/18
10/18
17:28
10/18/18
17:28
Hot Stocks
American Express says revenue growth 'directly' linked to company decisions »

Says revenue growth has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 05

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.